51 – 60 of 325
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
- Contribution to journal › Article
-
Mark
Analysis of plasma metabolomes from 11 309 subjects in five population-based cohorts
- Contribution to journal › Article
-
Mark
Abbreviated versus standard dual antiplatelet therapy times after percutaneous coronary intervention in patients with high bleeding risk with acute coronary syndrome : Insights from the swedeheart registry
- Contribution to journal › Article
-
Mark
Analysis of genetic variant associated with heart failure mortality implicates thymic stromal lymphopoietin as mediator of strain-induced myocardial fibroblast-mast cell crosstalk and fibrosis
- Contribution to journal › Article
-
Mark
Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events
- Contribution to journal › Article
-
Mark
Bacteraemia with gram-positive bacteria—when and how do I need to look for endocarditis?
- Contribution to journal › Scientific review
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
- Contribution to journal › Article
-
Mark
A randomised trial of selective intracoronary hypothermia during primary PCI
- Contribution to journal › Article
-
Mark
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
- Contribution to journal › Article
-
Mark
Rationale and design of INFINITY-SWEDEHEART : A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
- Contribution to journal › Article
